These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24639293)

  • 1. Implementation of an acute venous thromboembolism clinical pathway reduces healthcare utilization and mitigates health disparities.
    Misky GJ; Carlson T; Thompson E; Trujillo T; Nordenholz K
    J Hosp Med; 2014 Jul; 9(7):430-5. PubMed ID: 24639293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care disparities in the acute management of venous thromboembolism based on insurance status in the U.S.
    Misky GJ; Manheim JC; Zehnder N; Nguyen V; Swenson PF; Klem P; Trujillo T; Earnest MA
    J Thromb Thrombolysis; 2011 Nov; 32(4):393-8. PubMed ID: 21877234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-based disparities in venous thromboembolism outcomes: A National Inpatient Sample (NIS)-based analysis.
    Marshall AL; Bartley AC; Ashrani AA; Pruthi RK; Durani U; Gonsalves WI; Kapoor P; Hashmi SK; Siddiqui MA; Go RS
    Vasc Med; 2017 Apr; 22(2):121-127. PubMed ID: 28429667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism.
    Van Haren RM; Valle EJ; Thorson CM; Jouria JM; Busko AM; Guarch GA; Namias N; Livingstone AS; Proctor KG
    J Trauma Acute Care Surg; 2014 Feb; 76(2):443-9. PubMed ID: 24398771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
    Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
    J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma.
    Haut ER; Lau BD; Kraenzlin FS; Hobson DB; Kraus PS; Carolan HT; Haider AH; Holzmueller CG; Efron DT; Pronovost PJ; Streiff MB
    Arch Surg; 2012 Oct; 147(10):901-7. PubMed ID: 23070407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates.
    Mahan CE; Borrego ME; Woersching AL; Federici R; Downey R; Tiongson J; Bieniarz MC; Cavanaugh BJ; Spyropoulos AC
    Thromb Haemost; 2012 Aug; 108(2):291-302. PubMed ID: 22739656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in the Get With The Guidelines-Stroke acute ischemic stroke population: incidence and patterns of prophylaxis.
    Douds GL; Hellkamp AS; Olson DM; Fonarow GC; Smith EE; Schwamm LH; Cockroft KM
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):123-9. PubMed ID: 23253528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term complications of medical patients with hospital-acquired venous thromboembolism.
    Fanikos J; Piazza G; Zayaruzny M; Goldhaber SZ
    Thromb Haemost; 2009 Oct; 102(4):688-93. PubMed ID: 19806254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of venous thromboembolism in men admitted to a pneumology unit for acute respiratory disease].
    Aissa I; Rachdi I; Ben Miled K; Ghedira H
    Rev Pneumol Clin; 2011 Jun; 67(3):129-35. PubMed ID: 21665075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-cause and disease-related health care costs associated with recurrent venous thromboembolism.
    Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Hossou Y; Schein J; Kaatz S
    Thromb Haemost; 2013 Dec; 110(6):1288-97. PubMed ID: 24085327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism after major cancer surgery: temporal trends and patterns of care.
    Trinh VQ; Karakiewicz PI; Sammon J; Sun M; Sukumar S; Gervais MK; Shariat SF; Tian Z; Kim SP; Kowalczyk KJ; Hu JC; Menon M; Trinh QD
    JAMA Surg; 2014 Jan; 149(1):43-9. PubMed ID: 24197279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive risk factors of venous thromboembolism in autologous breast reconstruction surgery.
    Masoomi H; Paydar KZ; Wirth GA; Aly A; Kobayashi MR; Evans GR
    Ann Plast Surg; 2014 Jan; 72(1):30-3. PubMed ID: 24317244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
    Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
    J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of venous thromboembolism within the first year after Staphylococcus aureus bacteraemia: a nationwide observational matched cohort study.
    Mejer N; Westh H; Schønheyder HC; Jensen AG; Larsen AR; Skov R; Benfield T;
    J Intern Med; 2014 Apr; 275(4):387-97. PubMed ID: 24118528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic consequences of venous thromboembolism following major orthopedic surgery.
    Oster G; Ollendorf DA; Vera-Llonch M; Hagiwara M; Berger A; Edelsberg J
    Ann Pharmacother; 2004 Mar; 38(3):377-82. PubMed ID: 14742829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Venous thromboembolism in the elderly].
    Méan M; Aujesky D
    Rev Med Suisse; 2009 Oct; 5(223):2142-4, 2146. PubMed ID: 19968026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
    Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
    Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
    Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
    J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.